125 related articles for article (PubMed ID: 2868309)
1. Plasmodium falciparum resistant to mefloquine plus sulfadoxine/pyrimethamine.
Heizmann P; Fernex M; Leimer R; Reber-Liske R; Stohler H
Lancet; 1986 Feb; 1(8477):377. PubMed ID: 2868309
[No Abstract] [Full Text] [Related]
2. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
Win K; Thwe Y; Lwin TT; Win K
Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
[No Abstract] [Full Text] [Related]
3. Prospective double-blind trial of two different doses of mefloquine plus pyrimethamine-sulfadoxine compared with pyrimethamine-sulfadoxine alone in the treatment of falciparum malaria.
Botero D; Restrepo M; Montoya A
Bull World Health Organ; 1985; 63(4):731-7. PubMed ID: 3910296
[TBL] [Abstract][Full Text] [Related]
4. Single-dose therapy of falciparum malaria with mefloquine or pyrimethamine-sulfadoxine.
Doberstyn EB; Phintuyothin P; Noeypatimanondh S; Teerakiartkamjorn C
Bull World Health Organ; 1979; 57(2):275-9. PubMed ID: 373903
[TBL] [Abstract][Full Text] [Related]
5. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
[No Abstract] [Full Text] [Related]
6. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
[TBL] [Abstract][Full Text] [Related]
7. Double-blind dose finding study of mefloquine-sulfadoxine-pyrimethamine in children with acute falciparum malaria.
Guo XB; Arnold K; Fu LC; Chen PQ; Li GQ
Trans R Soc Trop Med Hyg; 1988; 82(4):538-40. PubMed ID: 3076709
[TBL] [Abstract][Full Text] [Related]
8. Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.
Li GQ; Arnold K; Guo XB; Jian HX; Fu LC
Lancet; 1984 Dec; 2(8416):1360-1. PubMed ID: 6150365
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of rodent malaria XXXV. Further studies on the retardation of drug resistance by the use of a triple combination of mefloquine, pyrimethamine and sulfadoxine in mice infected with P. berghei and 'P. berghei NS'.
Peters W; Robinson BL
Ann Trop Med Parasitol; 1984 Oct; 78(5):459-66. PubMed ID: 6395814
[TBL] [Abstract][Full Text] [Related]
10. A double-blind clinical trial of a combination of mefloquine, sulfadoxine and pyrimethamine in symptomatic falciparum malaria.
Ekue JM; Simooya OO; Sheth UK; Wernsdorfer WH; Njelesani EK
Bull World Health Organ; 1985; 63(2):339-43. PubMed ID: 3893778
[TBL] [Abstract][Full Text] [Related]
11. Trials of mefloquine in vivax and of mefloquine plus 'fansidar' in falciparum malaria.
Harinasuta T; Bunnag D; Lasserre R; Leimer R; Vinijanont S
Lancet; 1985 Apr; 1(8434):885-8. PubMed ID: 2858743
[TBL] [Abstract][Full Text] [Related]
12. [Plasmodium falciparum drug resistance and sulfadoxine-pyrimethamine in Africa].
Randriamanjaka JR; Le Bras J; Charmot G; Coulaud JP
Bull Soc Pathol Exot Filiales; 1989; 82(3):381-4. PubMed ID: 2670291
[TBL] [Abstract][Full Text] [Related]
13. Plasma and whole blood mefloquine concentrations during treatment of chloroquine-resistant falciparum malaria with the combination mefloquine-sulphadoxine-pyrimethamine.
Karbwang J; Looareesuwan S; Phillips RE; Wattanagoon Y; Molyneux ME; Nagachinta B; Back DJ; Warrell DA
Br J Clin Pharmacol; 1987 Apr; 23(4):477-81. PubMed ID: 3555581
[TBL] [Abstract][Full Text] [Related]
14. A double-blind trial of a fixed combination of mefloquine plus sulfadoxine-pyrimethamine compared with sulfadoxine-pyrimethamine alone in symptomatic falciparum malaria.
Ekue JM; Phiri DE; Sheth UK; Mukunyandela M
Bull World Health Organ; 1987; 65(3):369-73. PubMed ID: 3311440
[TBL] [Abstract][Full Text] [Related]
15. Combination treatment for falciparum prophylaxis.
White NJ
Lancet; 1987 Mar; 1(8534):680-1. PubMed ID: 2882095
[No Abstract] [Full Text] [Related]
16. The effect of mefloquine-sulfadoxine-pyrimethamine vs quinine on patients with complicated falciparum malaria.
Myint PT; Shwe T
Southeast Asian J Trop Med Public Health; 1987 Jun; 18(2):223-5. PubMed ID: 3313739
[TBL] [Abstract][Full Text] [Related]
17. Sequential treatment with quinine and mefloquine or quinine and pyrimethamine-sulfadoxine for falciparum malaria.
Hall AP; Doberstyn EB; Karnchanachetanee C; Samransamruajkit S; Laixuthai B; Pearlman EJ; Lampe RM; Miller CF; Phintuyothin P
Br Med J; 1977 Jun; 1(6077):1626-8. PubMed ID: 326337
[TBL] [Abstract][Full Text] [Related]
18. Quinine alone versus quinine plus a pyrimethamine-sulfadoxine combination in the treatment of Plasmodium faliciparum cerebral malaria.
Naparstek Y; Weiler-Ravell D; Shemer J; Englehard D; Sack J; Spira DT; Adler J
Am J Trop Med Hyg; 1981 Nov; 30(6):1342-3. PubMed ID: 7034564
[TBL] [Abstract][Full Text] [Related]
19. Mefloquine-pyrimethamine-sulfadoxine combination delays emergence of mefloquine resistant Plasmodium falciparum in continuous culture.
Tan-Ariya P; Brockelman CR; Menabandhu C
Southeast Asian J Trop Med Public Health; 1984 Dec; 15(4):531-5. PubMed ID: 6398918
[TBL] [Abstract][Full Text] [Related]
20. Antimalarial and toxic effect of triple combination of pyronaridine, sulfadoxine and pyrimethamine.
Shao BR; Huang ZS; Shi XH; Zhan CQ; Meng F; Ye XY; Huang J; Ha SH
Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):257-63. PubMed ID: 2692191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
